ODSH

DRUG3 trials

Sponsors

Jazz Pharmaceuticals, New York Medical College

Conditions

Acute Myeloid LeukemiaChronic Obstructive Pulmonary DiseaseNeuroblastomaRecurrent Solid TumorRefractory Solid TumorSarcomaWilms' Tumor

Early Phase 1

Ph I Safety and Efficacy of ODSH in Patients Receiving Induction or Consolidation Therapy for Acute Myeloid Leukemia

CompletedNCT01843634

Jazz PharmaceuticalsAcute Myeloid Leukemia

Start: 2013-08-31End: 2015-04-30Updated: 2021-11-10

Phase 1

ODSH + ICE Chemotherapy in Pediatric Solid Tumors

TerminatedNCT02164097

New York Medical CollegeNeuroblastoma, Recurrent Solid Tumor, Refractory Solid Tumor +2

Start: 2015-01-31End: 2017-12-31Updated: 2017-12-22

Phase 2

A Study Designed to Evaluate ODSH in Subjects With Exacerbations of COPD

TerminatedNCT00457951

Jazz PharmaceuticalsChronic Obstructive Pulmonary Disease

Start: 2007-04-30End: 2009-10-31Updated: 2021-12-02